Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Trupanion Inc. (TRUP) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Insurance - Property & Casualty
$28.20
+0.45 (1.62%)Did TRUP Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Trupanion is one of their latest high-conviction picks.
Based on our analysis of 12 Wall Street analysts, TRUP has a neutral consensus with a median price target of $39.50 (ranging from $31.00 to $59.00). The overall analyst rating is Buy (7.7/10). Currently trading at $28.20, the median forecast implies a 40.1% upside. This outlook is supported by 3 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Joshua Shanker at B of A Securities, projecting a 109.2% upside. Conversely, the most conservative target is provided by Jonathan Block at Stifel, suggesting a 9.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for TRUP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 14, 2026 | B of A Securities | Joshua Shanker | Buy | Maintains | $59.00 |
| Apr 9, 2026 | Cantor Fitzgerald | Ryan Tunis | Neutral | Maintains | $34.00 |
| Mar 31, 2026 | Stifel | Jonathan Block | Hold | Maintains | $31.00 |
| Feb 13, 2026 | Stifel | Jonathan Block | Hold | Maintains | $35.00 |
| Feb 13, 2026 | Piper Sandler | John Barnidge | Overweight | Maintains | $45.00 |
| Jan 29, 2026 | Stifel | Jonathan Block | Hold | Maintains | $38.00 |
| Jan 14, 2026 | Cantor Fitzgerald | Ryan Tunis | Neutral | Maintains | $42.00 |
| Dec 19, 2025 | Piper Sandler | John Barnidge | Overweight | Maintains | $60.00 |
| Nov 18, 2025 | Stifel | Jonathan Block | Hold | Maintains | $42.00 |
| Aug 8, 2025 | Stifel | Jonathan Block | Hold | Maintains | $45.00 |
| Aug 8, 2025 | Piper Sandler | John Barnidge | Overweight | Maintains | $67.00 |
| Jul 3, 2025 | Piper Sandler | John Barnidge | Overweight | Maintains | $62.00 |
| May 2, 2025 | Lake Street | Mark Argento | Buy | Maintains | $60.00 |
| Feb 20, 2025 | Piper Sandler | John Barnidge | Overweight | Maintains | $52.00 |
| Feb 20, 2025 | Stifel | Jonathan Block | Hold | Maintains | $41.00 |
| Jan 23, 2025 | Piper Sandler | John Barnidge | Overweight | Upgrade | $57.00 |
| Jan 6, 2025 | Stifel | Jonathan Block | Hold | Maintains | $44.00 |
| Oct 31, 2024 | Northland Capital Markets | Greg Gibas | Market Perform | Maintains | $50.00 |
| Oct 31, 2024 | Piper Sandler | John Barnidge | Neutral | Maintains | $57.00 |
| Oct 2, 2024 | Piper Sandler | John Barnidge | Neutral | Maintains | $45.00 |
The following stocks are similar to Trupanion based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Trupanion Inc. has a market capitalization of $1.22B with a P/E ratio of 62.7x. The company generates $1.44B in trailing twelve-month revenue with a 1.4% profit margin.
Revenue growth is +11.7% quarter-over-quarter, while maintaining an operating margin of +2.2% and return on equity of +5.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Offers health insurance for pets.
The company generates revenue by providing tailored health insurance plans for cats and dogs, focusing on comprehensive coverage for veterinary expenses. Its direct-to-consumer model enhances customer experience and retention, while partnerships with veterinary hospitals streamline the claims process and reduce out-of-pocket costs for pet owners.
Trupanion operates primarily in North America and is positioned in the growing pet care market, which is fueled by rising pet ownership and increasing awareness of pet insurance benefits. The company's integration of technology with financial services supports responsible pet ownership and contributes to the overall pet healthcare ecosystem.
Financial Services
Insurance - Property & Casualty
1,121
Ms. Margaret Rosemary Maria Tooth
United States
2014
Trupanion, Inc. (Nasdaq: TRUP) will report its Q1 2026 financial results on April 30, 2026, after market close, followed by a conference call at 1:30 p.m.
Trupanion's upcoming financial results and conference call could impact stock performance, providing insights into growth and market positioning in the pet insurance sector.
The US pet insurance market grew over 10% in 2025, continuing its annual expansion since 2018. The industry's net loss ratio improved to 74.2% from 76.1% in 2024.
The consistent growth and improving net loss ratio in the pet insurance market signal strong demand and operational efficiency, indicating potential profitability for investors.
On Feb. 27, 2026, 2,837 shares were sold at $26.46 each, totaling ~$75,000. This sale eliminated Qureshi's direct and indirect ownership of common stock.
The complete divestment of Qureshi's holdings may signal a lack of confidence in the company's future prospects, potentially impacting stock price and investor sentiment negatively.
HABRI partners with Trupanion to enhance the human-animal bond, combining research and innovative pet insurance, including support for veterans and service dogs.
The partnership enhances Trupanion's brand visibility and credibility, potentially driving customer loyalty and sales in the growing pet insurance market, impacting investor sentiment positively.
Trupanion upgraded to Buy after its first GAAP profit. Gross margins increased to 16%, targeting 14% subscription revenue growth by 2026 amid low U.S. pet insurance penetration.
Trupanion's upgrade to Buy signals strong financial health, improved margins, and growth potential in a low-penetration market, positioning it for sustainable cash flow and expansion.
Trupanion, Inc. (Nasdaq: TRUP) will present at the BofA Securities 2026 Animal Health Summit on February 26, 2026, with CEO Margi Tooth and CFO Fawwad Qureshi scheduled for 12:25 p.m.
Trupanion's participation in investor conferences highlights its visibility and engagement with the investment community, potentially influencing stock performance and investor sentiment.
Based on our analysis of 12 Wall Street analysts, Trupanion Inc. (TRUP) has a median price target of $39.50. The highest price target is $59.00 and the lowest is $31.00.
According to current analyst ratings, TRUP has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $28.20. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict TRUP stock could reach $39.50 in the next 12 months. This represents a 40.1% increase from the current price of $28.20. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by providing tailored health insurance plans for cats and dogs, focusing on comprehensive coverage for veterinary expenses. Its direct-to-consumer model enhances customer experience and retention, while partnerships with veterinary hospitals streamline the claims process and reduce out-of-pocket costs for pet owners.
The highest price target for TRUP is $59.00 from Joshua Shanker at B of A Securities, which represents a 109.2% increase from the current price of $28.20.
The lowest price target for TRUP is $31.00 from Jonathan Block at Stifel, which represents a 9.9% increase from the current price of $28.20.
The overall analyst consensus for TRUP is neutral. Out of 12 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $39.50.
Stock price projections, including those for Trupanion Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.